Jan Beute
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phosphodiesterase-3 Inhibitor Enoximone in SARS-CoV-2 Infection.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: September 08, 2021
Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report.
Journal: Canadian respiratory journal
Published: June 23, 2021
PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia.
Journal: Experimental lung research
Published: February 05, 2021
Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children.
Journal: International journal of pediatrics & adolescent medicine
Published: November 03, 2020
PDE3 Inhibition Reduces Epithelial Mast Cell Numbers in Allergic Airway Inflammation and Attenuates Degranulation of Basophils and Mast Cells.
Journal: Frontiers in pharmacology
Published: December 07, 2019
A pathophysiological role of PDE3 in allergic airway inflammation.
Journal: JCI insight
Published: May 16, 2017
Emergency treatment of status asthmaticus with enoximone.
Journal: British journal of anaesthesia
Published: March 19, 2014
Cardiac output measured by uncalibrated arterial pressure waveform analysis by recently released software version 3.02 versus thermodilution in septic shock.
Journal: Journal of clinical monitoring and computing
Published: June 15, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026